{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:13:25Z","timestamp":1789586005914,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471084"],"award-info":[{"award-number":["81471084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1405220"],"award-info":[{"award-number":["U1405220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31470726"],"award-info":[{"award-number":["31470726"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773793"],"award-info":[{"award-number":["81773793"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31770814"],"award-info":[{"award-number":["31770814"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["20720150052"],"award-info":[{"award-number":["20720150052"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012176","name":"Programme of Introducing Talents of Discipline to Universities","doi-asserted-by":"publisher","award":["B12001"],"award-info":[{"award-number":["B12001"]}],"id":[{"id":"10.13039\/501100012176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China for Fostering Talents in Basic Research","doi-asserted-by":"publisher","award":["J1310027"],"award-info":[{"award-number":["J1310027"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.bbagen.2018.07.022","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T14:10:17Z","timestamp":1532355017000},"page":"2261-2270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Structural basis for the hepatoprotective effects of antihypertensive 1,4-dihydropyridine drugs"],"prefix":"10.1016","volume":"1862","author":[{"given":"Yijuan","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benqiang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2018.07.022_bb0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1389557033488141","article-title":"The 1,4-dihydropyridine nucleus: a pharmacophoric template part 1. Actions at ion channels","volume":"3","author":"Triggle","year":"2003","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature19102","article-title":"Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs","volume":"537","author":"Tang","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2018.07.022_bb0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1291\/hypres.26.383","article-title":"Effect of cilnidipine on insulin sensitivity in patients with essential hypertension","volume":"26","author":"Yagi","year":"2003","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0020","first-page":"67","article-title":"New generations of dihydropyridines for treatment of hypertension","volume":"14","author":"Wang","year":"2017","journal-title":"J. Geriatr. Cardiol."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0025","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1749-6632.1988.tb33427.x","article-title":"Protection of liver by calcium entry blockers","volume":"522","author":"Thurman","year":"1988","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0030","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jsps.2015.04.004","article-title":"Effect of amlodipine, lisinopril and allopurinol on acetaminophen-induced hepatotoxicity in rats","volume":"24","author":"Mohammed","year":"2016","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0035","first-page":"391","article-title":"Nimodipine, a dihydropyridine-type calcium channel blocker, prevents alcoholic hepatitis caused by chronic intragastric ethanol exposure in the rat","volume":"24","author":"Iimuro","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2018.07.022_bb0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0300-9572(91)90033-U","article-title":"Influence of nicardipine on post-hypoxic injury in the isolated perfused rat liver","volume":"22","author":"Fujita","year":"1991","journal-title":"Resuscitation"},{"key":"10.1016\/j.bbagen.2018.07.022_bb0045","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2018.07.022_bb0050","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2018.07.022_bb0055","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbagen.2018.07.022_bb0060","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s40495-017-0085-2","article-title":"Role of FXR in liver inflammation during nonalcoholic steatohepatitis","volume":"3","author":"Armstrong","year":"2017","journal-title":"Curr. Pharmacol. Rep."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.phrs.2017.04.021","article-title":"Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling","volume":"121","author":"Gu","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0075","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbagrm.2016.03.002","article-title":"Nuclear receptors and nonalcoholic fatty liver disease","volume":"1859","author":"Cave","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2018.07.022_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbadis.2017.10.003","article-title":"Farnesoid X receptor: A \"homeostat\" for hepatic nutrient metabolism","volume":"1864","author":"Massafra","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2018.07.022_bb0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bbagrm.2014.05.021","article-title":"Bile acid signaling and liver regeneration","volume":"1849","author":"Fan","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2018.07.022_bb0090","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1152\/physiol.00020.2008","article-title":"The role of FXR in disorders of bile acid homeostasis","volume":"23","author":"Eloranta","year":"2008","journal-title":"Physiology"},{"key":"10.1016\/j.bbagen.2018.07.022_bb0095","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1210\/me.2010-0117","article-title":"Activation of the farnesoid X receptor provides protection against acetaminophen-induced hepatic toxicity","volume":"24","author":"Lee","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0100","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1124\/dmd.111.038414","article-title":"Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1\/2-mediated phosphorylation of CCAAT\/enhancer binding protein beta","volume":"39","author":"Noh","year":"2011","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0105","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1210\/me.2009-0286","article-title":"FXR regulates liver repair after CCl4-induced toxic injury","volume":"24","author":"Meng","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0110","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbrc.2013.11.057","article-title":"Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease","volume":"443","author":"Wu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0115","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1016\/j.bmc.2013.04.069","article-title":"Development of time resolved fluorescence resonance energy transfer-based assay for FXR antagonist discovery","volume":"21","author":"Yu","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/srep06437","article-title":"Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor","volume":"4","author":"Hsu","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0125","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.taap.2016.10.017","article-title":"Differential modulation of FXR activity by chlorophacinone and ivermectin analogs","volume":"313","author":"Hsu","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0130","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.molcel.2005.02.002","article-title":"Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1","volume":"17","author":"Li","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbagen.2018.07.022_bb0135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0140","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0145","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.molcel.2005.06.026","article-title":"Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor","volume":"19","author":"Li","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbagen.2018.07.022_bb0150","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1016\/j.bmcl.2009.06.062","article-title":"FXR agonist activity of conformationally constrained analogs of GW 4064","volume":"19","author":"Akwabi-Ameyaw","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0155","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jbt.20042","article-title":"Diverse antioxidants protect against acetaminophen hepatotoxicity","volume":"18","author":"Oz","year":"2004","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0160","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/03602530802186587","article-title":"Modulating GSH synthesis using glutamate cysteine ligase transgenic and gene-targeted mice","volume":"40","author":"Botta","year":"2008","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0165","doi-asserted-by":"crossref","first-page":"28857","DOI":"10.1074\/jbc.M011610200","article-title":"Human bile salt export pump promoter is transactivated by the farnesoid X receptor\/bile acid receptor","volume":"276","author":"Ananthanarayanan","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","article-title":"Clinical development success rates for investigational drugs","volume":"32","author":"Hay","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0175","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/534314a","article-title":"Can you teach old drugs new tricks?","volume":"534","author":"Nosengo","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2018.07.022_bb0180","doi-asserted-by":"crossref","first-page":"83S","DOI":"10.1016\/S0895-7061(01)02074-X","article-title":"Role of endothelin-1 in hypertension and vascular disease","volume":"14","author":"Schiffrin","year":"2001","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0185","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/01.RES.0000200400.55539.85","article-title":"Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells","volume":"98","author":"He","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0190","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCRESAHA.109.212969","article-title":"Farnesoid X receptor activation prevents the development of vascular calcification in ApoE\u2212\/\u2212 mice with chronic kidney disease","volume":"106","author":"Miyazaki-Anzai","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0195","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/hep.26939","article-title":"Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats","volume":"59","author":"Verbeke","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bbagen.2018.07.022_bb0200","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2016.12.005","article-title":"The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction","volume":"66","author":"Schwabl","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbagen.2018.07.022_bb0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(16)31919-5","article-title":"Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2018.07.022_bb0210","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0140-6736(16)00002-7","article-title":"From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century","volume":"388","author":"Blacher","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2018.07.022_bb0215","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.tips.2009.11.002","article-title":"Recent advances and method development for drug target identification","volume":"31","author":"Chan","year":"2010","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416518302137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416518302137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T03:53:28Z","timestamp":1759636408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416518302137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0304416518302137"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2018.07.022","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural basis for the hepatoprotective effects of antihypertensive 1,4-dihydropyridine drugs","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2018.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}